CYTOCHROME-P450 CYP3A5 IN THE HUMAN ANTERIOR-PITUITARY GLAND

被引：30
|
作者：
MURRAY, GI
PRITCHARD, S
MELVIN, WT
BURKE, MD
机构：
[1] UNIV ABERDEEN, DEPT MOLEC & CELL BIOL, ABERDEEN AB9 2ZD, SCOTLAND
[2] UNIV ABERDEEN, DEPT BIOMED SCI, ABERDEEN AB9 2ZD, SCOTLAND
来源：
FEBS LETTERS | 1995年 / 364卷 / 01期
关键词：
CYTOCHROME P450; PITUITARY GLAND; SOMATOTROPH;
D O I：
10.1016/0014-5793(95)00367-I
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The cytochromes P450 are a key group of enzymes involved in the metabolism of xenobiotics and several biologically active endogenous compounds. The expression of CYP3A5 has been identified by reverse transcriptase-polymerase chain reaction in human pituitary gland and shown by immunohistochemistry to be localized to growth hormone containing cells of the anterior pituitary gland. This is the first direct identification of an individual P450 subfamily in the pituitary gland and the presence of CYP3A in the pituitary gland may play a role in regulating growth hormone secretion.
引用
收藏
页码：79 / 82
页数：4
相关论文
共 50 条
  • [31] THYROXINE 5'-DEIODINASE IN HUMAN ANTERIOR-PITUITARY TUMORS
    ITAGAKI, Y
    YOSHIDA, K
    IKEDA, H
    KAISE, K
    KAISE, N
    YAMAMOTO, M
    SAKURADA, T
    YOSHINAGA, K
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (02): : 340 - 344
  • [32] ANALYSIS OF HUMAN CYTOCHROME-P450 CATALYTIC ACTIVITIES AND EXPRESSION
    GONZALEZ, FJ
    CRESPI, CL
    CZERWINSKI, M
    GELBOIN, HV
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 168 (02): : 67 - 72
  • [33] HUMAN CYTOCHROME-P450 MONOOXYGENASE SYSTEM IS SUPPRESSED BY PROPOFOL
    CHEN, TL
    UENG, TH
    CHEN, SH
    LEE, PH
    FAN, SZ
    LIU, CC
    BRITISH JOURNAL OF ANAESTHESIA, 1995, 74 (05) : 558 - 562
  • [34] Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes
    Silva, JM
    Day, SH
    Nicoll-Griffith, DA
    CHEMICO-BIOLOGICAL INTERACTIONS, 1999, 121 (01) : 49 - 63
  • [35] EFFECT OF 5-FLUOROCYTOSINE AND 5-FLUOROURACIL ON HUMAN AND RAT HEPATIC CYTOCHROME-P450
    INSELMANN, G
    HOLZLOHNER, U
    HEIDEMANN, HT
    MYCOSES, 1989, 32 (12) : 638 - 643
  • [36] Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients
    Lepper, ER
    Baker, SD
    Permenter, M
    Ries, N
    van Schaik, RHN
    Schenk, PW
    Price, DK
    Ahn, D
    Smith, NF
    Cusatis, G
    Ingersoll, RG
    Bates, SE
    Mathijssen, RHJ
    Verweij, J
    Figg, WD
    Sparreboom, A
    CLINICAL CANCER RESEARCH, 2005, 11 (20) : 7398 - 7404
  • [37] CYTOCHROME-P450 CYP1A EXPRESSION IN THE PANCREATIC-ISLETS OF LANGERHANS
    BARNETT, CR
    CLARKE, J
    MCCLENAGHAN, NH
    FLATT, PR
    DIABETOLOGIA, 1995, 38 : A135 - A135
  • [38] A 3-DIMENSIONAL MODEL OF AROMATASE CYTOCHROME-P450
    GRAHAMLORENCE, S
    AMARNEH, B
    WHITE, RE
    PETERSON, JA
    SIMPSON, ER
    PROTEIN SCIENCE, 1995, 4 (06) : 1065 - 1080
  • [39] Cytochrome P450CYP3A in human renal cell cancer
    Murray, GI
    McFadyen, MCE
    Mitchell, RT
    Cheung, YL
    Kerr, AC
    Melvin, WT
    BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) : 1836 - 1842
  • [40] Cytochrome P450 oxidoreductase variant A503V contributes to the increased CYP3A5 activity with tacrolimus in vitro
    Gao, Yuan
    Ma, Jingjing
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (7-8) : 529 - 535
12345